TerrAscend (TSNDF) Common Equity (2020 - 2026)
TerrAscend's (TSNDF) quarterly Common Equity came in at $90.9 million in Q1 2026, down 44.92% year-on-year from $165.1 million in Q1 2025, and down 8.16% on a QoQ basis from $99.0 million in Q4 2025.
TerrAscend (TSNDF) Common Equity (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Common Equity data on file, last reported at $90.9 million in Q1 2026.
- On a quarterly basis, Common Equity fell 44.92% year-over-year to $90.9 million in Q1 2026; TTM through Mar 2026 was $90.9 million, a 44.92% decrease from a year earlier, with the FY2025 full-year figure at $99.0 million, down 44.0% from the prior year.
- Common Equity for Q1 2026 stood at $90.9 million, down from $99.0 million in the prior quarter.
- Over the last five years, Common Equity for TSNDF reached as high as $580.0 million in Q2 2022 and fell as low as $90.9 million in Q1 2026.
- Historically, Common Equity has averaged $249.1 million across 5 years, with a median of $232.1 million in 2024.
- Across the five-year window, Common Equity surged 186.77% in 2022 and tumbled 53.9% in 2025, its largest moves.
- Year by year, Common Equity stood at $321.2 million in 2022, then decreased by 25.04% to $240.7 million in 2023, then dropped by 26.55% to $176.8 million in 2024, then slumped by 44.0% to $99.0 million in 2025, then declined by 8.16% to $90.9 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $90.9 million in Q1 2026, $99.0 million in Q4 2025, and $95.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 90.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.94 Mn |
| Dec 31, 2025 | 99.02 Mn |
| Sep 30, 2025 | 95.48 Mn |
| Jun 30, 2025 | 118.39 Mn |
| Mar 31, 2025 | 165.11 Mn |
| Dec 31, 2024 | 176.82 Mn |
| Sep 30, 2024 | 207.12 Mn |
| Jun 30, 2024 | 226.15 Mn |
| Mar 31, 2024 | 232.11 Mn |
| Dec 31, 2023 | 240.74 Mn |
| Sep 30, 2023 | 284.78 Mn |
| Jun 30, 2023 | 293.93 Mn |
| Mar 31, 2023 | 299.30 Mn |
| Dec 31, 2022 | 321.17 Mn |
| Sep 30, 2022 | 278.82 Mn |
| Jun 30, 2022 | 579.98 Mn |
| Mar 31, 2022 | 525.24 Mn |
| Dec 31, 2021 | 228.95 Mn |
| Sep 30, 2021 | 212.75 Mn |
| Jun 30, 2021 | 202.74 Mn |